As a national referral center for the diagnosis, treatment, and follow-up of patients with pulmonary hypertension, our unit has identified a 9.4% prevalence of epithelial neoplasms in a cohort of 32 patients with heritable PAH due to BMPR2 mutation. This evidence concerns the gene BMPR2 and pulmonary arterial hypertension.